biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Consequences of a "no" vote: from IR

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Jan 20, 2023 6:59pm

107 Views

Post# 35236768

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Consequences of a "no" vote: from IR

,,,and xB3 wont have one red cent put towrds its development,,no schedule avaialble,,it might be a fall back to for Biodexa,,,,,,,nothing has been told to us when or ever will our technology be utilized,,,,,nothing,,,,,nada,,,,,so why are we being merge,,,taken out,,,,,if we are worthless,,,,,lmao,,,,,!!,,you cant make this stuff up,,,,,its as plain as the big red veiny nose on Midatechs face,,,,,,and if they butcher it in the Spring we wont get a roast!!!

<< Previous

Bullboard Posts

Next >>

Gold Flora's Gramlin holds court in California cannabis market